Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma (opens ClinicalTrials.gov)
- Sponsor
- Hyogo Medical University
- Enrolment
- 25
- Started
- 2024-03-13
- Last update
- 2026-09-16
Conditions: Malignant Pleural Mesothelioma
Interventions: Lenvatinib, Pemetrexed, Cisplatin/Carboplatin, Pembrolizumab